Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- "PFAS Testing Market by Product Type (Instrument (LC-MS, GC, NMR), Consumables (Coloumns, Solvents, Reagents), Software), Technique (LC- MS-MS, CIC), Method (EPA, ISO, DIN, ASTM), Application (Water, F&B, Soil, Air, Blood/Serum) - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.
The global PFAS testing market is projected to expand from USD 429.2 million in 2024 to USD 969.5 million by 2030, registering a CAGR of 14.5%
The report provides stakeholders with an accurate estimation of the PFAS testing market and its segments. It helps market entrants understand the competitive landscape and craft effective market strategies. Detailed analysis of market drivers, constraints, opportunities, and challenges is provided.
Advanced mass spectrometry and chromatography technologies are significantly improving contaminant detection accuracy and efficiency. However, the market faces challenges due to the lack of standardized test methods for PFAS analysis in matrices other than drinking water, impacting regulatory and data accuracy issues across industries like agriculture, packaging, and wastewater management.
The technique segment to hold the largest share of the market in 2023.
PFAS testing is categorized into techniques such as LC-MS-MS, GC/MS, mass spectrometry, NMR spectroscopy, and others. The LC-MS-MS segment dominated the market in 2023, owing to the integration of liquid chromatography with advanced tandem mass spectrometers. This integration enables high-throughput analysis with minimal sample preparation, enhancing accuracy and sensitivity. Such advancements have broadened the application across industries such as pharmaceuticals, environmental monitoring, and food safety analysis.
The EPA segment to hold the largest share of the market in 2023.
The market segments for PFAS testing include EPA, DIN, ISO, ASTM, among others. The EPA segment is set to lead due to rising awareness about the health hazards of PFAS contaminants, linked to diseases like cancer and liver dysfunction. Global regulatory bodies are tightening PFAS limits, driving the demand for precise testing protocols. EPA-validated methodologies like EPA 537, 533, and 8327 are preferred due to their sensitivity and specificity in analyzing multiple PFAS compounds. This focus on environmental protection and public health continues to drive EPA-based testing solutions.
The market in the North America region is expected to hold a significant market share for PFAS testing in 2024.
North America led the PFAS testing market owing to stringent government regulations, robust enforcement strategies, and heightened consumer awareness about PFAS hazards. Increased investments in environmental study and remediation are boosting new PFAS testing technology adoption. Regulatory frameworks by the U.S. EPA and Environment Canada emphasize stringent PFAS monitoring, contributing to market dominance. Future investments in lab facilities and advanced methods will likely sustain North America's leadership in the PFAS testing market.
Key Companies Profiled in the Report:
Leading market players include Merck KGaA (Germany), Agilent Technologies (US), LGC Limited (UK), Waters Corporation (US), Biotage (Sweden), AccuStandard, Inc. (US), PerkinElmer, Inc. (US), Thermo Fisher Scientific, Inc. (US), Phenomenex (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and Shimadzu Corporation (Japan).
Key Benefits of Buying the Report
- Analysis of key drivers (regulatory reforms, public awareness, investment climate, financial support for projects).
- Product Development/Innovation: Insights on technologies, R&D activities, product launches in PFAS testing.
- Market Development: Comprehensive information about lucrative markets and regional analysis.
- Market Diversification: Information on new products, geographies, and investments.
- Competitive Assessment: Analysis of market shares, strategies, and offerings of leading players, including recent developments and financial metrics in the PFAS testing market.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 332 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $429.2 Million |
| Forecasted Market Value (USD) by 2030 | $969.5 Million |
| Compound Annual Growth Rate | 14.5% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Regulatory Reforms Addressing Environmental Pollution
- Growing Concerns Over PFAS Contamination in Water
- Favorable Investment Climate Driving Improvements in Environmental Capabilities
- Increasing Financial Support for Wastewater Treatment Projects and Programs
Challenges
- Lack of Standardized Testing Methods Across Regions
- Limited Availability of Skilled Labor
Opportunities
- Growth Opportunities Presented by Major Markets
- Growing Financial Support for Treatment Projects and Programs
- Higher Public Awareness Regarding Population Levels
Company Profiles
- Agilent Technologies, Inc.
- Danaher Corporation
- Waters Corporation.
- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- Merck KGaA
- Perkinelmer Inc.
- Lgc Limited
- Biotage
- Macherey-Nagel GmbH & Co. KG
- Accustandard
- Wellington Laboratories Inc.
- Cambridge Isotope Laboratories, Inc.
- Chiron As
- Metrohm Inula GmbH
- Restek Corporation
- Microsaic
- Evonik
- Lctech
- Absolute Standards Inc.
- Cytiva
- Avantor, Inc.
- Greyhound Chromatography and Allied Chemicals Ltd.
- Lanxess
- The Chemours Company
For more information about this report visit https://www.researchandmarkets.com/r/5n22em
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
